Benzinga | Aug 10, 2020 07:25AM EDT

Zynerba Pharmaceuticals Q2 EPS $(0.78) Misses $(0.45) Estimate

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.45) by 73.33 percent. This is a 56 percent decrease over losses of $(0.50) per share from the same period last year.